Acute effect of pretreatment with single conventional dose of salmeterol on dose-response curve to oxitropium bromide in chronic obstructive pulmonary disease

Thorax

Volumn 54, Issue 12, 1999, Pages 1083-1086

  Cazzola, Mario ^a,d   Di Perna, Felice ^a   Centanni, Stefano ^b   Califano, Clara ^a   Donner, Claudio Ferdinando ^c   D'Amato, Maria ^a   D'Amato, Gennaro ^a  

^a CARDARELLI HOSPITAL   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c IRCCS   (Italy)

^d NONE   (Italy)

Author keywords

Chronic obstructive pulmonary disease; Combination therapy; Oxitropium bromide; Salmeterol

Indexed keywords

CHOLINERGIC RECEPTOR BLOCKING AGENT; IPRATROPIUM BROMIDE; MUSCARINIC RECEPTOR BLOCKING AGENT; OXITROPIUM BROMIDE; PLACEBO; SALMETEROL;

ADULT; AGED; ARTICLE; BRONCHODILATATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG MEGADOSE; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; INHALATIONAL DRUG ADMINISTRATION; MALE; PRIORITY JOURNAL;

EID: 0032744998     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thx.54.12.1083     Document Type: Article

References (22)

1. COPD Guidelines Group of the Standards of Care Committee of the BTS. BTS guidelines for the management of chronic obstructive pulmonary disease. Thorax 1997;52 (Suppl 5):S1-28.
2. Combivent Inhalation Aerosol Study Group. In chronic obstructive pulmonary disease, a combination of ipratropium and albuterol is more effective than either agent alone. Chest 1994;105:1411-9.
3. Levin DC, Little KS, Laughlin KR, et al. Addition of anticholinergic solution prolongs bronchodilator effect of beta 2 agonists in patients with chronic obstructive pulmonary disease. Am J Med 1906;100 (Suppl 1A):40-8S.
4. Cazzola M, Spina D, Matera MG. The use of bronchodilators in stable chronic obstructive pulmonary disease. Pulm Pharmacol Ther 1997;10:129-44.
5. 4-agonists be considered an alternative first choice option for the treatment of stable COPD? Respir Med 1999;93:227-9.
6. 4-agonists and theophylline in stable chronic obstructive pulmonary disease. Thorax 1990;54:730-6.
7. Matera MG, Capuri M, Cazzola M. A combination with clinical recommended dosages of salmeterol and ipratropium is not more effective than salmeterol alone in patients with chronic obstructive pulmonary disease. Respir Med 1996;90:197-9.
8. Sichletidis L, Kottakis J, Marcou S, et al. Bronchodilatory responses to formoterol, ipratropium, and their combination in patients with stable COPD. Int J Clin Pract 1999;53:185-8.
9. American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1995;152:S72-120.
10. American Thoracic Society. Standardization of spirometry: 1987 Update. Am Rev Respir Dis 1987;136:1285-98.
11. Chapman KR. Clinical implications of anticholinergic hronchodilator therapy in COPD. Res Clin Forums 1991;13 (2 part 1):43-50.
12. Campbell S. For COPD a combination of ipratropium bromide and albuterol sulfate is more effective than albuterol base. Arch Intern Med 1999;159:156-60.
13. Brown IG, Chan CS, Kelly CA, et al. Assessment of the clinical usefulness of nebulised ipratropium bromide in patients with chronic airflow limitation. Thorax 1984;39: 272-6.
14. Marlin GE. Studies of ipratropium bromide and fenoterol administered by metered-dose inhaler and aerosolized solution. Respiration 1986;50(Suppl 2):290-3.
15. Barros MJ, Rees PJ. Bronchodilator responses to salbutamo followed by ipratropium bromide in partially reversible airflow obstruction. Respir Med 1990;84:371-5.
16. Cazzola M, Santangelo G, Piccolo A, et al. Effect of salmeterol and formoterol in patients with chronic obstructive pulmonary disease. Pulm Pharmacol 1994;7:103-7.
17. Matera MG, Cazzola M, Vinciguerra A, et al. A comparison of the bronchodilating effects of salmeterol, salbutamol and ipratropium bromide in patients with chronic obstructive pulmonary disease. Pulm Pharmacol 1995;8:267-71.
18. Cazzola M, Matera MG, Di Perna F, et al. A comparison of bronchodilating effects of salmeterol and oxitropium bromide in stable chronic obstructive pulmonary disease. Respir Med 1998;92:354-7.
19. Ikeda A, Nishimura K, Koyama H, et al. Comparative doseresponse study of three anticholinergic agents and fenoterol using a metered dose inhaler in patients with chronic obstructive pulmonary disease. Thorax 1995;50:62-6.
20. Peel ET, Anderson G. A dose response study of oxitropium bromide in chronic bronchitis. Thorax 1984;39:453-6.
21. Lal S, Eyre-Brook A, Mitra SK, et al. Oxitropium bromide in chronic bronchitis. Res Clin Forums 1991;13(2, part 2):29-36.
22. Skorodin MS, Gross NJ, Moritz T, et al. Oxitropium bromide, a new anticholinergic bronchodilator. Ann Allergy 1986;56:229-32.